Dopamine-induced ganglionic inhibition
Mongrel dogs (4 to 8 kg) were anaes thetized with pentobarbitone sodium 30 mg/ kg i.v. The ganglionic preparation was previously described in detail (Willems, 1973) . Bipolar electrodes were placed on the cut upper internodal segment of the fourth or fifth paravertebral lumbar ganglion and an electrical stimulus of 0.3 ms duration and supramaximal intensity was applied at a frequency of 1 Hz. Postganglionic electrical activity was recorded by a second bipolar electrode on the ramus communicans grise us of the ganglion. Drugs were injected into the abdominal aorta at the level of the ganglion studied.
Dopamine and apo morphine were used as agonists, domperidone as the antagonist.
Dopamine-induced neurogenic vasodilatation
Mongrel dogs (8 to 15 kg) were anaes thetized with pentobarbitone sodium 30 kg/ kg i.v. The isolated perfused hindleg pre paration was previously described in detail (Willems and Bogaert, 1975) . The isolated hindleg was perfused at a constant flow with the dog's own blood and changes in perfusion pressure reflect changes in vascular resistance. Drugs were injected into the abdominal aorta at the level of L5. Dopamine was used as the agonist and domperidone and haloperidol as antagonists.
Apomorphine-induced vasodilatation
Mongrel dogs (10 to 20 kg) were anaesthetized with pentobarbitone sodium 30 mg/kg i.v. Blood flow in both femoral arteries was monitored with electromagnetic flowmeters.
Drugs were injected locally into the femoral artery via the arteria femoralis profunda (Buylaert et al., 1977) . Apomor phine was used as an agonist and domperi done and haloperidol as antagonists.
a. Dopamine, 16.10-8 moles, injected into the abdominal aorta, elicited in 5 dogs an inhibition of the postsynaptic spike of 81.37% ±8.59 (mean±S.E.M.).
This dopamine induced ganglionic inhibition was antagoni zed by 30 ,ag of domperidone: after domperidone, dopamine 16.10-8 moles gave an inhibition of 13.40%±4.97 (P<0.01).
b. I n a series of 10 dogs, domperidone or haloperidol was administered in three doses, 1, 10 and 100 ug at 30 min interval. In another 5 dogs the solvent (lactic acid 0.1 N) was injected. The neurogenic vasodilatation, elicited by 16.10-8 moles of dopamine injected into the abdominal aorta, obtained after a given dose of the antagonist is expressed as a percent of the control neuro genic vasodilatation. Table 1 summarizes the results obtained. Solvent injections did not modify the dopamine neurogenic vasodilatation.
c. Apomorphine, 0.25-0.5 . 10-8 moles, injected directly into the femoral artery, elicits a specific, short-lasting vasodilatation without any systemic effect. This vasodila tation is due to an inhibitory effect of apomor phine on the transmitter release from the sympathetic nerve endings. This effect is mediated by a specific dopamine receptor (Buylaert et al., 1977; Enero and Langer, 1975; Long et al., 1975) . Table 2 summarizes the results obtained with domperidone (4 experiments) and with haloperidol (7 experi ments).
The increase in femoral flow is given as a percent of the preexisting flow.
Haloperidol and domperidone, in a dose of about 10 iig, blocked the apomorphine induced vasodilatation to a great extent and a competitive antagonism may be involved here.
The neurogenic vasodilatation elicited in the isolated perfused hindleg by the intra aortic administration of dopamine, is due to an inhibitory effect on the paravertebral sympathetic ganglia (Willems and Bogaert, 1975) . Furthermore this dopamine-induced ganglionic inhibition is mediated by a specific dopamine receptor, which is blocked Table 1 . Neurogenic vasodilatation (% of control) by dopamine 16.10-8 moles given intraaortically after increasing doses of haloperidol and domperidone (mean±S.E.M.) Table 2 . Increase in femoral flow (% of previous resting flow) by apomorphine (0.25 -0 .5.10-5 moles) given intraarterially before and after haloperidol (n=7) or domperidone (n=4)` (Mean±S.E.M.)
'0 .5.10-5 moles apomorphine was used when 0.25.10-5 moles did not produce a marked vasodilatation, in such a case 30 ug was used for haloperidol.
by haloperidol (Willems, 1973) . The results presented herein show that domperidone also antagonizes this specific dopamine effect and that in that respect it is equipotent with haloperidol.
The apomorphine-induced vasodilatation in the femoral vascular bed is due to an interaction with a receptor which has the characteristics of a dopamine receptor: the effect can selectively be blocked by haloperidol and (+)-butaclamol but not by (-)-butaclamol (Buylaert et al., 1977) . Our results show that domperidone and haloperidol are equipotent as antagonists of these effects on peripheral dopamine receptors.
